

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Sichuan Huiyu Pharmaceutical: HY07121 (Subcutaneous Injection) Clinical Trial Application Accepted by NMPA

Sichuan Huiyu Pharmaceutical: HY07121 (Subcutaneous Injection) Clinical Trial Application Accepted by NMPA

Jun 15, 2026 15:54 CST Updated 16:37

Share:

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.